Generics and biosimilars offer quality therapies and sustainable health care, EGA meeting hears
“Savings of an additional 16 billion euros ($21.9 billion) per annum could be achieved by increasing generic medicines volume in key areas related to the aging population,” Steven Simoens, a professor at the Katholieke Universiteit Leuven said at an event organized by the European Generic medicines Association (EGA) under the patronage of the Belgian Presidency and hosted by Anne Delvaux, Member of the European Parliament.
On this occasion, around 100 stakeholders gathered in the European Parliament to discuss patient access to affordable treatments and healthcare sustainability in the perspective of an increasing aging population.
EU faces aging population and falling birth rate
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Generics
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze